Alex John Ntamatungiro

In the News

IHI team engages with top brass at SERI

The IHI team (right) led by Dr. Honorati Masanja (not seen on the photo) meets with SERI officials (left row) during a stakeholder engagement meeting in Bern last week. PHOTO/COURTESY …

Health professionals learn “One Health” approach

Dr. Ally Olotu stresses a point when he addressed participants and invited guests during the opening ceremony. PHOTO/IHIcoms (Bagamoyo, Aprili 5 2019) Health professionals from Zoonotic disease risk areas of …

Recent Projects

Calcium supplementation on pregnant women

Project summary This is a trial-based study funded by the Bill and Melinda Gates Foundation. It intends to generate evidence for decision-making on the potential non-inferiority of a lower dose …

Sustainable, Healthy, Learning Cities and Neighbourhoods

The Sustainable, Healthy, Learning Cities and Neighbourhoods is an exciting project in which IHI works with a consortium of partners from Asia and Africa to 1) develop capacity for improved …

Alex John Ntamatungiro

Research Scientist

He is a molecular biologist. His research focus is on molecular biology of infectious disease. Alex currently works at the Chronic Diseases Clinic-Ifakara (CDCI). His current research is on HIV-drug resistance dynamics. His routine work involves; PCR test for HIV Early Infants Diagnosis, HIV-viral load measurements and Genetic sequencing for HIV-drug resistance mutations analysis. His previous research was supported by research grants from Wellcome-Trust and Grand Challenge Canada. Alex was himself a Wellcome Trust Masters Research Fellow until 2014, during which time he worked on sub-microscopic malaria infections, before eventually joining the HIV team.

 View Alex’s Research Interests and Publications

Projects

Kilombero and Ulanga antiretroviral cohort study (KIULARCO)

Epidemiology and molecular monitoring of HIV drug resistance in Tanzania

A PIXELBASE DESIGN
© Ifakara Health Institute (IHI), 2016